A new study from research firm Best Practices reveals how pharmas can best use their oncology Web sites. The company studied 17 top-selling oncology drugs from nine companies and found that high performers design their Web sites to include and complement both product-specific and corporate branding. The study also revealed significant gaps between the information and services that pharmas provide online and what patients and key opinion leaders want. The company says pharmas should work to better align their offerings with consumer needs. The study also concluded that companies can use their oncology sites as a platform to provide clinical trials resources. Doing this will not only help inform constituents, but also help recruit potential participants and investigators. |
0 comments:
Post a Comment